22nd International AIDS Conference *

July 23-27, 2018; Amsterdam, The Netherlands
Engage in this scientific analysis of AIDS 2018, with downloadable slides and expert faculty commentary on key HIV prevention and treatment studies.

Share

Program Content

8 Capsule Summaries

Activities

DRIVE-FORWARD: Week 96 Follow-up
DRIVE-FORWARD: Durable Virologic Efficacy With Doravirine Plus NRTIs vs Darunavir/Ritonavir Plus NRTIs Through Week 96 in ART-Naive Patients
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2018

BRIGHTE Subgroup Analysis
BRIGHTE: Fostemsavir Plus OBT Associated With Similar Virologic Efficacy in Most Subgroups of Heavily Treatment–Experienced Patients at Week 24
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2018

SWORD-1, -2: Week 100 Follow-up
SWORD-1 and -2: Durable Virologic Efficacy Through Week 100 With Switch From Baseline ART to DTG Plus RPV in Virologically Suppressed Patients
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2018

E/C/F/TAF and M184V/I
Study 1824: Virologic Suppression Maintained in Patients With M184V/I Mutation After Switch to EVG/COBI/FTC/TAF
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2018

GEMINI-1 and -2
GEMINI-1 and -2: Dual-Therapy With DTG Plus 3TC Noninferior to DTG Plus FTC/TDF in Treatment-Naive Patients at Week 48
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2018

Tsepamo: DTG and Neural Tube Defects
Tsepamo: Preliminary Data Suggest Increased Risk of Neural Tube Defects With Dolutegravir Exposure at Conception
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2018

Prevenir Interim Analysis
Prevenir: Interim Analysis Shows High Efficacy of Daily or On-Demand PrEP Among MSM
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2018

PARTNER2
PARTNER2: Risk of HIV Transmission From HIV-Positive Partner on Suppressive ART Is Effectively Zero for MSM
Capsule Summary
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2018

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Janssen

ViiV Healthcare

Partners

AIDS 2018

ProCE Banner

IAS 2018

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.